This filing is part of the company’s quarterly result. Read the full results article, with every figure explained →
Standalone Q3 revenue falls 2% to Rs 53.62 crore; profit after tax dips 5% to Rs 5.85 crore
VESUVIUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 2.5 pts less than its Electrodes & Refractories peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Standalone quarter ended September 30, 2026: revenue from operations fell 1.99% to Rs 53.62 crore from Rs 54.70 crore a year earlier; profit after tax fell 4.92% to Rs 5.85 crore from Rs 6.15 crore. Standalone nine-month revenue fell 26.17% to Rs 155.36 crore and profit after tax fell 30.38% to Rs 18.39 crore. Auditors gave an unmodified review opinion. The Mehsana sale to Foseco India is expected by December 31, 2026; no gain is booked yet.
Lower Q3 profit and a 26% nine-month revenue drop point to pressure. The Mehsana sale may add cash, but it is incomplete and no gain is booked.
| Q2 FY27 | Q2 FY26 | Change | |
|---|---|---|---|
| Revenue | ₹566.8 Cr | ₹547.0 Cr | +3.6% |
| Operating profit | ₹69.04 Cr | ₹75.46 Cr | −8.5% |
| Profit after tax | ₹57.10 Cr | ₹61.54 Cr | −7.2% |
| EBITDA margin | 15.5% | 16.9% | −1.4 pp |
From the company's XBRL filing, not from the text above. Operating profit = profit before tax − exceptional items − other income. EBITDA = profit before tax + finance costs + depreciation − other income.